Thematic Pro

Causal claim

Gene Therapy ✚ Uniqure

Gene Therapy enables Uniqure.

The two move together: more cause, more effect. The map scores it at 66% confidence, weighed from 5 articles.

• EnablesRelation
• +Polarity
• 66%Confidence
• unknownLag
• UnspecifiedStrength
• ActiveStatus

How it works

AMT-130 landmark trial success advances uniQure's HD gene therapy program toward clinical validation

The evidence

• 5Backing articles
• 5Publishers
• 5Evidence records
• Sep 2025–Jun 2026Coverage

• Illustration B

  UniQure Shares Soar After FDA Reversal on Its Huntington's Therapy

  Bloomberg · Jun 17, 2026 Standard

  Backs 2 claims

  • Fda Approval ✚ Uniqure
  • Gene Therapy ✚ Uniqure

  Read article →
• Illustration R

  UniQure to seek approval for Huntington's therapy after FDA U-turn, shares skyro...

  Reuters · Jun 17, 2026 Standard

  Backs 2 claims

  • Fda Approval ✚ Uniqure
  • Gene Therapy ✚ Uniqure

  Read article →
• B

  UniQure plans Q3 submission for Huntington’s gene therapy after FDA reverses course—again

  biospace.com · Jun 17, 2026 Standard

  Backs 2 claims

  • Fda Approval ✚ Uniqure
  • Gene Therapy ✚ Uniqure

  Read article →
• F

  UniQure stock surges after FDA U-turn clears path to gene therapy filing

  fiercebiotech.com · Jun 17, 2026 Standard

  Backs 3 claims

  • Fda Approval ✚ Uniqure
  • Gene Therapy ✚ Fda Approval
  • Gene Therapy ✚ Uniqure

  Read article →
• Illustration E

  The First Domino Falls: AMT-130 Gene Therapy Slows Huntington’s in Landmark Trial – HDBuzz

  en.hdbuzz.net · Sep 24, 2025 Standard

  Backs 2 claims

  • Gene Therapy ↓ Neurodegeneration
  • Gene Therapy ✚ Uniqure

  Read article →

Where it sits

See it on the live map →